Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-27T06:50:24.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Cis-platinum associated hearing loss

Published online by Cambridge University Press:  29 June 2007

Leonard P. Rybak
Leonard P. Rybak*
Affiliation:
Minnesota, Minneapolis
*
Dr. L. P. Rybak, Assistant Professor of Otolaryngology, University of Minnesota, 412 Union Street SE, Minneapolis, MN 55455.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical records
Information
The Journal of Laryngology & Otology , Volume 95 , Issue 7 , July 1981 , pp. 745 - 747
Copyright
Copyright © JLO (1984) Limited 1981

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

DeConti, R. C., Toftness, B. R., Lange, R. C., and Creasey, W. A. (1973) Clnical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Research, 33, 1310–1315.Google Scholar
Einhorn, L. H., and Williams, S. D. (1979) Current concepts in cancer. The role of cis-platinum in solid-tumor therapy. New England Journal of Medicine, 300, 289–291.CrossRefGoogle Scholar
Gormley, P. E., Bull, J. M., Leroy, A. F., and Cysyk, R. (1979) Kinetics of cisdichlorodiammineplatinum. Clinical Pharmacology and Therapeutics, 25, 351–357.CrossRefGoogle ScholarPubMed
Hayes, D. M., Cvitkovic, E., Golbey, R. B., et al. (1977) High dose cis-platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer, 39, 1372–1381.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
Helson, L., Okonkwo, E., Anton, L., and Cvitkovic, E. (1978) Cis-platinum ototoxicity. Clinical Toxicology, 13, 469–478.CrossRefGoogle ScholarPubMed
Higby, D. J., Wallace, H. J. Jr., Albert, D., and Holland, J. F. (1974) Diamminodichloroplatinum in the chemotherapy of testicular tumors. Journal of Urology, 112, 100–104.CrossRefGoogle ScholarPubMed
Kovach, J. S., Moertel, C. G., Schutt, A. J., et al. (1973) Phase II study of cis-diamminedichloroplatinum (NS-119875) in advanced carcinoma of the large bowel. Cancer Chemotherapy Reports, 57, 357–359.Google ScholarPubMed
Lippman, A. J., Helson, C, Helson, L., and Krakoff, I. H. (1973) Clinical trials of cis-diamminedichloroplatinum (NSC-119875). Cancer Chemotherapy reports, 57, 191–200.Google ScholarPubMed
Pera, M. F. Jr., and Harder, H. C. (1979) Effects of mannitol or furosemide diuresis on cis-dichlorodiammine platinum (II) antitumor activity and toxicity to host-renewing cell populations in rats. Cancer Research, 39, 1279–1286.Google ScholarPubMed
Pera, M. F., Zook, B. C., and Harder, H. C. (1979). Effects of mannitol orfurosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammine platinum (II) in rats. Cancer Research, 39, 1269–1278.Google Scholar
Piel, I. J., Meyer, D., Perlia, C. P., and Wolfe, V. I. (1974) Effects of cis-diammine-dichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemotherapy Reports, 58, 871–875.Google ScholarPubMed
Rosenberg, B. (1977) Noble metal complexes in cancer chemotherapy. Advances in Experimental Medicine and Biology, 91, 129–150.CrossRefGoogle ScholarPubMed